Delivery Order SPE2DB24D3013-SPE2DB24FFHKF

Award Date 8/29/24
Potential Completion Date 8/30/24
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,494.05 contract is for the supply of 4,567,951,867 units of the diabetes medication Jardiance 25 mg tablets. The award has an ultimate completion date of April 18, 2025 and was made on April 17, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 4,565,634,277 units of the medication Jardiance 25 mg tablets in packages of 90. The contract has a ceiling value of $4,139.99 and an ultimate completion date of August 30, 2024. It is a Firm Fixed Price contract with no set-aside designation. AmerisourceBergen holds several...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,876.74, is for the delivery of 4,567,957,360 units of the diabetes medication Jardiance 25 mg tablets. The contract has an ultimate completion date of April 18, 2025 and is not set aside for a specific business type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Jardiance 25 mg tablets. The contract has a firm fixed price of $3,635.43 and an ultimate completion date of September 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Jardiance 25 mg tablets, with a firm fixed price of $1,558.31 and a completion date of July 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,246.25 contract is for the supply of 4,568,142,360 units of the diabetes medication Jardiance 25 mg tablets. The award has a completion date of May 6, 2025 and is not set aside for any specific business type. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,395.70, is for the supply of 4,568,142,300 units of the diabetes medication Jardiance 25 mg tablets. The contract has a performance period through May 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,597,600 units of the prescription drug Jardiance 10 mg tablets. The contract has a ceiling value of $12,887.67 and an ultimate completion date of August 28, 2024. It is a firm-fixed-price contract, which means AmerisourceBergen will receive a predetermined amount for each unit delivered. This award is part of a larger Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,062.29, is for the supply of 4,568,175,266 units of the prescription medication Jardiance 25 mg tablets. The contract has an ultimate completion date of May 8, 2025. AmerisourceBergen Drug Corp is a for-profit organization and a registered vendor in SAM.gov. The company holds a significant Indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $18,181.82 fixed-price contract is for the supply of Jardiance 25 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB24FFHKF
    Delivery Order

This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,565,632,291 units of the medication Jardiance 25 mg tablets, at a firm fixed price of $8,055.11. The contract has an ultimate completion date of August 30, 2024. AmerisourceBergen is a for-profit organization and the contract does not have a set-aside designation. This award is part of a larger IDC valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and supplies, to support military treatment programs and facilities worldwide.

Generated 11/28/24, 9:14 AM